For the active substances 1-naphthylacetamide, 1-naphthylacetic acid, bifenox, esfenvalerate, etofenprox, fenpyrazamine, fluazifop P, napropamide, paraffin oils, prohexadione, spiroxamine, tetraconazole and tri-allate, the risk assessment pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 has not yet been finalised by the respective rapporteur Member States.
Recital 7, Regulation (EU) 2023/2592
In forcesince 21 Nov 2023
- celex=32012R0844